Evaluation of Three Strategies Based on Vaginal Self-sampling Kit Send to Home of Unscreened Women for Cervical Cancer
NCT03856684 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10400
Last updated 2021-10-29
Summary
Despite the existence of an effective screening test (pap smear), cervical cancer is, every year in France, the cause of more than 3,000 new cases and 1,100 deaths. But, in France, 4 in 10 women are not screened or not often enough (nearly 7 millions women). It is therefore necessary to develop new strategies to reach these women. The etiological factor of this cancer is persistent infection with High-Risk Human PapillomaVirus (HR-HPV). Thereby, HPV-based tests could be alternative screening tests. Vaginal self-sampling with HR-HPV test is simpler and less intrusive than the pap smear. It has been shown that sending vaginal self-sampling kit (with HPV test) to unscreened women's home is a powerful means to increase the participation rate of cervical cancer screening. It seems interesting to explore methods to increase the efficiency of this strategy by optimizing the ratio of the number of kits used compared to the number of kits sent. Two approaches will be tested: a system "available on request" of the kit and / or the addition of an SMS (Short Message Service) reminder.
Conditions
- Cervical Cancer Screening
- Cervical Cancer
Interventions
- BEHAVIORAL
-
Self-sampling kit sent at home
Selected women receive a mail inviting them either to perform a vaginal self sampling at their home (with the kit provided) or to perform a pap smear. When women choose the vaginal self-sampling, a HPV test is performed on the sample in a virology laboratory.
- BEHAVIORAL
-
Self-sampling kit sent at home + SMS reminder
Selected women receive a mail inviting them either to perform a vaginal self sampling at their home (with the kit provided) or to perform a pap smear. After 2 months without "return", a SMS reminder about the available self-sampling kit is sent to the woman. We call "return" : * the receipt of the vaginal self-sample at the laboratory * the performance of a pap smear * Information about recent screening test or a cervical screening exclusion reason When women choose the vaginal self-sampling, a HPV test is performed on the sample in a virology laboratory.
- BEHAVIORAL
-
Letter offering a self-sampling kit "on request"+ SMS reminder
Selected women receive a mail inviting them either to perform a vaginal self sampling at their home (kit provided on request) or to perform a pap smear. Women are invited to ask the kit online, on our website. For the women who ask the kit, after 2 months without "return", a SMS reminder about the available self-sampling kit is sent to the woman. We call "return" : * the receipt of the vaginal self-sample at the laboratory * the performance of a pap smear * Information about recent screening test or a cervical screening exclusion reason When women choose the vaginal self-sampling, a HPV test is performed on the sample in a virology laboratory.
- BEHAVIORAL
-
SMS offering a self-sampling kit "on request"+ SMS reminder
Selected women receive a SMS inviting them to ask a vaginal self sampling kit to perform a sample at home and send it to a laboratory (kit provided on request). Women are invited to ask the kit by answering "1" by SMS. For the women who ask the kit, after 2 months without "return", a SMS reminder about the available self-sampling kit is sent to the woman. We call "return" : * the receipt of the vaginal self-sample at the laboratory * the performance of a pap smear * Information about recent screening test or a cervical screening exclusion reason When women choose the vaginal self-sampling, a HPV test is performed on the sample in a virology laboratory.
Sponsors & Collaborators
-
Centre Régional de Coordination des Dépistages des Cancers - Centre-Val de Loire
collaborator UNKNOWN -
Centre d'Investigation Clinique-P1415, TOURS
collaborator UNKNOWN -
University Hospital, Tours
lead OTHER
Principal Investigators
-
Julie BOYARD, MSc · University Hospital of TOURS
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SCREENING
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 30 Years
- Max Age
- 66 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-02-11
- Primary Completion
- 2021-07-14
- Completion
- 2021-10-20
Countries
- France
Study Locations
More Related Trials
-
HPV Self-sampling in the General Population
NCT06749847 ·Status: RECRUITING ·Phase: NA
-
Cervical Cancer Screening Uptake: A Randomised Controlled Trial Assessing the Effect of Sending Invitation Letters to Nonadherent Women
NCT04689178 ·Status: UNKNOWN ·Phase: NA
-
Carrying Out of Focus Group to Improve Cervical Screening Proposal by Vaginal Self-sampling (APACHE-4/FG).
NCT03420157 ·Status: COMPLETED
-
Self-Sampling in Women Who Do Not Undergo Routine Cervical Screening
NCT00977392 ·Status: COMPLETED
-
Improving Access to Cervical Cancer Screening
NCT03118258 ·Status: UNKNOWN ·Phase: NA
-
A Proximity-incentive Strategy for Cervical Cancer Screening
NCT04716127 ·Status: COMPLETED ·Phase: NA
-
Combined Incentive Actions, Focusing on Primary Care, to Improve Cervical Cancer Screening in Women Residing in Socio-economically Disadvantaged and Untracked Geographical Areas: a Hybrid Efficacy and Implementation Trial
NCT04312178 ·Status: COMPLETED ·Phase: NA
-
Participation in Screening for Cervical Cancer: Interest of a Self-sampling Device Provided by the General Practitioner
NCT02749110 ·Status: COMPLETED ·Phase: NA
-
Acceptability of HPV-self Sampling
NCT03137563 ·Status: COMPLETED
-
Randomized Trial of In-Home Cervical Cancer Screening in Underscreened Women
NCT02005510 ·Status: COMPLETED ·Phase: NA
-
Feasibility and Acceptability of Offering Self-sampling to Non-attendees in Primary Care
NCT02698423 ·Status: COMPLETED ·Phase: NA
-
Acceptability of HPV Self-sampling Among Canadian Women Aged 21 to 65
NCT05414929 ·Status: UNKNOWN ·Phase: NA
-
Self-sampling Among Long-term Non-attenders to Cervical Cancer Screening
NCT03873376 ·Status: COMPLETED ·Phase: NA
-
Self Collected Sampling in Non-attendees Cervical Cancer Screening: DNA Test and Molecular Triage for HPV Positive Women
NCT03183700 ·Status: UNKNOWN ·Phase: NA
-
Cervical Cancer Screening Intervention Among Korean American Women
NCT02594826 ·Status: COMPLETED ·Phase: NA
-
Uniting Trusted Community Messengers to Improve Access to Cervical Cancer Screening in Rural North Carolina
NCT07294066 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Self-Collection and Human Papillomavirus (HPV) Testing in Unscreened Women: a Feasibility Study in Brazil
NCT03713697 ·Status: COMPLETED ·Phase: NA
-
Cervical Cancer Screening of Postmenopausal Women in Low- and Middle-income Countries Using HPV Self-sampling and Triage by Genotyping and Cytology
NCT07244315 ·Status: COMPLETED
-
Self-sampling for Non-participants in an Organised Cervical Cancer Screening Programme
NCT02680262 ·Status: COMPLETED ·Phase: NA
-
Telehealth & HPV Self-Collection
NCT05089825 ·Status: COMPLETED ·Phase: NA
-
HPV Self-sampling for Women Who do Not Attend Cervical Cancer Screening Programme
NCT06371118 ·Status: RECRUITING ·Phase: NA
-
Breast Cancer-Related Approach for Increasing Cervical Cancer Screening
NCT07171658 ·Status: RECRUITING ·Phase: NA
-
The Potential for HPV Self-testing to Promote Participation in Cervical Screening
NCT02779621 ·Status: WITHDRAWN ·Phase: NA
-
Human Papilloma Virus (HPV) Self-collection and Women Adherence
NCT05059015 ·Status: UNKNOWN ·Phase: NA
-
Acceptability and Efficacy of Self-sampling for Cervical Cancer Screening: A Pilot Study
NCT03813576 ·Status: UNKNOWN ·Phase: NA